Share-based Payment Arrangement, Expense in USD of PURE BIOSCIENCE, INC. from Q4 2012 to 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pure Bioscience, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q4 2012 to 2025.
  • Pure Bioscience, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Oct 2024 was $57K, a 28.8% decline year-over-year.
  • Pure Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $144K, a 32.7% decline from 2024.
  • Pure Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $214K, a 18.3% decline from 2023.
  • Pure Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $262K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PURE BIOSCIENCE, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $57K -$23K -28.8% 01 Aug 2024 31 Oct 2024 10-Q 16 Dec 2024
Q3 2023 $80K +$17K +27% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024
Q3 2022 $63K -$106K -62.7% 01 Aug 2022 31 Oct 2022 10-Q 14 Dec 2023
Q3 2021 $169K -$39K -18.8% 01 Aug 2021 31 Oct 2021 10-Q 14 Dec 2022
Q3 2020 $208K -$60K -22.4% 01 Aug 2020 31 Oct 2020 10-Q 15 Dec 2021
Q4 2019 $477K $68K -$176K -72.1% 01 Nov 2019 31 Jan 2020 10-Q 12 Mar 2020
Q3 2019 $653K $268K -$734K -73.3% 01 Aug 2019 31 Oct 2019 10-Q 15 Dec 2020
Q2 2019 $1.39M $58K 01 May 2019 31 Jul 2019 10-K 08 Oct 2020
Q1 2019 $83K -$143K -63.3% 01 Feb 2019 30 Apr 2019 10-Q 13 Jun 2019
Q4 2018 $244K -$212K -46.5% 01 Nov 2018 31 Jan 2019 10-Q 12 Mar 2020
Q3 2018 $1M 01 Aug 2018 31 Oct 2018 10-Q 13 Dec 2019
Q1 2018 $226K 01 Feb 2018 30 Apr 2018 10-Q 13 Jun 2019
Q4 2017 $456K 01 Nov 2017 31 Jan 2018 10-Q 06 Mar 2019
Q2 2016 $1.9M $281K -$350K -55.5% 01 May 2016 31 Jul 2016 10-K 27 Oct 2016
Q1 2016 $2.25M $186K -$580K -75.7% 01 Feb 2016 30 Apr 2016 10-Q 09 Jun 2016
Q4 2015 $2.83M $763K +$281K +58.3% 01 Nov 2015 31 Jan 2016 10-Q 09 Mar 2016
Q3 2015 $2.55M $672K +$169K +33.6% 01 Aug 2015 31 Oct 2015 10-Q 10 Dec 2015
Q2 2015 $2.38M $631K -$136K -17.7% 01 May 2015 31 Jul 2015 10-K 27 Oct 2016
Q1 2015 $2.52M $766K -$4K -0.52% 01 Feb 2015 30 Apr 2015 10-Q 09 Jun 2016
Q4 2014 $2.52M $482K -$850K -63.8% 01 Nov 2014 31 Jan 2015 10-Q 09 Mar 2016
Q3 2014 $3.37M $503K +$414K +465% 01 Aug 2014 31 Oct 2014 10-Q 10 Dec 2015
Q2 2014 $2.96M $767K 01 May 2014 31 Jul 2014 10-K 28 Oct 2015
Q1 2014 $770K +$617K +403% 01 Feb 2014 30 Apr 2014 10-Q 11 Jun 2015
Q4 2013 $1.33M +$1.09M +450% 01 Nov 2013 31 Jan 2014 10-Q 04 Mar 2015
Q3 2013 $89K 01 Aug 2013 31 Oct 2013 10-Q 11 Dec 2014
Q1 2013 $153K 01 Feb 2013 30 Apr 2013 10-Q 10 Jun 2014
Q4 2012 $242K 01 Nov 2012 31 Jan 2013 10-Q 13 Mar 2014

PURE BIOSCIENCE, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $144K -$70K -32.7% 01 Aug 2024 31 Jul 2025 10-K 29 Oct 2025
2024 $214K -$48K -18.3% 01 Aug 2023 31 Jul 2024 10-K 29 Oct 2025
2023 $262K 01 Aug 2022 31 Jul 2023 10-K 29 Oct 2024
2021 $758K +$203K +36.6% 01 Aug 2020 31 Jul 2021 10-K 28 Oct 2021
2020 $555K -$832K -60% 01 Aug 2019 31 Jul 2020 10-K 08 Oct 2020
2019 $1.39M -$138K -9.05% 01 Aug 2018 31 Jul 2019 10-K 08 Oct 2020
2018 $1.53M 01 Aug 2017 31 Jul 2018 10-K 30 Oct 2019
2016 $1.9M -$480K -20.2% 01 Aug 2015 31 Jul 2016 10-K 27 Oct 2016
2015 $2.38M -$576K -19.5% 01 Aug 2014 31 Jul 2015 10-K 27 Oct 2016
2014 $2.96M +$2.24M +311% 01 Aug 2013 31 Jul 2014 10-K 28 Oct 2015
2013 $720K 01 Aug 2012 31 Jul 2013 10-K 28 Oct 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.